Update on pharmacotherapy of myoclonic seizures-Reference-Cited by-同舟云学术

Update on pharmacotherapy of myoclonic seizures

Published:2017-01-22 Issue:2 Volume:18 Page:187-193
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Striano Pasquale¹,Belcastro Vincenzo²

Affiliation:

1. Pediatric Neurology and Muscular Diseases Unit, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, ‘G. Gaslini’ Institute, Genova, Italy

2. Neurology Unit, Department of Medicine, Sant’Anna Hospital, Como, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1280459

Reference70 articles.

1. Classification of the Myoclonic Epilepsies

2. Pathophysiology of Myoclonic Seizures

3. Current understanding and neurobiology of epileptic encephalopathies

4. Treatment of myoclonic seizures

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Strategies to Ameliorate Neuronal Damage in Epilepsy by Regulating Oxidative Stress, Mitochondrial Dysfunction, and Neuroinflammation;Brain Sciences;2023-05-11

2. Perampanel for the treatment of patients with myoclonic seizures in clinical practice: Evidence from the PERMIT study;Seizure;2022-08

3. Alternatives to valproate in girls and women of childbearing potential with Idiopathic Generalized Epilepsies: state of the art and guidance for the clinician proposed by the Epilepsy and Gender Commission of the Italian League Against Epilepsy (LICE);Seizure;2021-02

4. Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update;Acta Neurologica Belgica;2020-10-13

5. Lessons learned from the discovery of sodium valproate and what has this meant to future drug discovery efforts?;Expert Opinion on Drug Discovery;2020-07-20